Noetik

IntroductionWhat is Perturb-Map?Why do we think Perturb-Map is better than most animal studies?How do we use Perturb-Map to find the overlap between mouse biology and human biology?Conclusion, and the active-learning loop TL;DR: Human data is directly rel

tldr: At Noetik, we build foundation models of patient biology. Accordingly, we generate data best suited for molecularly characterizing patient tissue to train these models. However, the specific modality of data we believe is the richest-18,963-plex spa

IntroductionScaling behaviorParameter + context length scalingData scalingConclusiontl;dr: We have trained a new self-supervised model across thousands of human cancer spatial transcriptomes, nicknaming it TARIO. We have found that the model exhibits scal

We are announcing a five-year foundation model licensing agreement with GSK today.This is a huge milestone for NOETIK, but it also represents a shift for the biopharma industry: the move from AI services collaborations to licensing of biological foundatio

Note: this is part three of a series of three posts discussing how the therapeutics team at Noetik have used our virtual cell model, OCTO-VC, for practically useful, therapeutics-relevant tasks. The Introduction section will stay the same for each one, sk

Note: this is part two of a series of three posts discussing how the therapeutics team at Noetik have used our virtual cell model, OCTO-VC, for practically useful, therapeutics-relevant tasks. The Introduction section will stay the same for each one, skip

Note: this is part of a series of three posts discussing how the therapeutics team at Noetik have used our virtual cell model, OCTO-VC, for practically useful, therapeutics-relevant tasks. The Introduction section will stay the same for each one, skip dow